ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Myeloma in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Plasma Cell Cancer
Lymphoma
Hematologic Cancer
Cancer
Leukemia
Smoldering Multiple Myeloma
Non-Hodgkin Lymphoma

Multiple Myeloma trials near Boston, MA, USA:

Elranatamab in R/R Multiple Myeloma

if the study drug, elranatamab, reduces the risk of disease progression (worsening disease) after idecabtagene vicleucel in relapsed refractory multiple...

Enrolling
Multiple Myeloma
Relapse Multiple Myeloma
Drug: Elranatamab

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 2 other locations

This research study is evaluating a new drug called "ixazomib" as a possible treatment for Smoldering Multiple Myeloma....

Active, not recruiting
Smoldering Multiple Myeloma
Drug: Lenalidomide
Drug: Ixazomib

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States

This research study is studying a combination of study drugs as a possible treatment for relapsed and refractory Multiple Myeloma. ...

Active, not recruiting
Multiple Myeloma
Drug: Dexamethasone
Drug: Elotuzumab

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 5 other locations

pomalidomide, and dexamethasone in relapsed and refractory multiple myeloma. The study drugs provided for research purposes are isa...

Not yet enrolling
Multiple Myeloma
Refractory Multiple Myeloma
Drug: Dexamethasone
Drug: Isatuximab

Phase 2

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 1 other location

of three drugs called lenalidomide, subcutaneous (injection under the skin) bortezomib, and dexamethasone (RVD) as a possible treatment for multiple...

Active, not recruiting
Multiple Myeloma
Drug: Dexamethasone
Procedure: Stem Cell Mobilization

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 7 other locations

This research study is studying a targeted therapy as a possible treatment for multiple myeloma.The names of the study drugs involv...

Enrolling
Multiple Myeloma
Drug: Trametinib
Drug: Dabrafenib

Phase 1

Mass General Brigham
Mass General Brigham

Boston, Massachusetts, United States and 1 other location

The purpose of this study is to evaluate three daratumumab dose schedules in participants with Smoldering Multiple Myeloma....

Active, not recruiting
Multiple Myeloma
Drug: daratumumab

Phase 2

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Boston, Massachusetts, United States and 56 other locations

and safety of bb2121 in participants with relapsed and refractory multiple myeloma (RRMM) (Cohort 1), in participants with RRMM who ...

Enrolling
Multiple Myeloma
Biological: bb2121
Drug: Talquetamab

Phase 2

Celgene
Celgene

Boston, Massachusetts, United States and 25 other locations

a registration, open-label phase 1 study of the combination of ibrutinib/lenalidomide:/dexamethasone in women and men with relapsed/refractory multiple...

Active, not recruiting
Multiple Myeloma in Relapse
Multiple Myeloma
Drug: Lenalidomide
Drug: Dexamethasone

Phase 1

Alliance Foundation Trials

Boston, Massachusetts, United States and 4 other locations

(DRd) to that of lenalidomide and dexamethasone (Rd), in terms of progression-free survival in participants with relapsed or refractory multiple...

Active, not recruiting
Multiple Myeloma
Drug: Daratumumab
Drug: Lenalidomide

Phase 3

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Boston, Massachusetts, United States and 145 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems